Table 3

Individual data of the participants

PatientAgeSexDiagnosisSettingMedicationΔHAMD
Diagnosis: 1, major depressive disorder, single episode, moderate; 2, major depressive disorder, recurrent, moderate; 3, bipolar I disorder, most recent episode depressed, moderate; 4, bipolar I disorder, most recent episode depressed, severe; 5, dysthymic disorder.
Medication: 1, lithium carbonate; 2, carbamazepine; 3, tricyclic antidepressant; 4, selective serotonin reuptake inhibitor (SSRI); 5, monoaminooxidase inhibitors; 6, l-thyroxine; 7, neuroleptic; 8, sedative.
ΔHAMD, Reduction in the Hamilton Rating Scale of Depression between both assessments before and at the end of the training programme.
159f3Outpatient1,2,4,6−8
246m2,5Outpatient1,3−5
336m2Outpatient30
442f1,5Outpatient6,7,4−2
548f2Outpatient3,6−8
628m2Outpatient3,4,7−15
764m2Outpatient1−2
858m4Inpatient1,7,8−14
958f4Inpatient1,2−14
1049f2Inpatient1,7−6
1156f2Inpatient1,5−3
1256f4Inpatient6,70